AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Protein-based therapy helps the body remove harmful cells

Scientists have created a protein-based therapeutic tool that could change the way we treat...

Diabetes changes the structure of our hearts, study finds

Type 2 diabetes directly alters the heart's structure and energy systems, which explains why...

Beta blockers could halt triple negative breast cancer

Researchers have identified a molecular biomarker in triple negative breast cancer tumours which...

Content from other channels on our network

SA launches strategy to "virtually eliminate HIV transmission" by 2030

High-end heritage: expanded St Vincent's Private Hospital, Fitzroy

Revised 2025 edition of Australian Asthma Handbook now available

AdPha marks World Patient Safety Day with Medication Safety article series

Tas doctors "strongly oppose" any taxpayer-funded home birth scheme

New CEO for Sydney Water

Cardboard creates sustainable construction material

Tyre recycling project addresses mining industry waste

How AI is empowering renewable energy in Australia

Australia's 2035 climate target announced

Not all mercury is toxic: bluefin tuna study reveals more

Packaging partnership to develop compostable lidding

Beef processor achieves AUS-MEAT approval for carcase grading

How will Australia's new climate targets impact manufacturing?

Award-winning design on Johnnie Walker Bottles uses digital inkjet technology